Figure 2 from: Elitova S, Naseva E, Getova-Kolarova V, Getov I (2026) Delphi study on barriers to the implementation of a national clinical pharmacy practice guideline – results from Bulgaria. Pharmacia 73: e189960. https://doi.org/10.3897/pharmacia.73.e189960

Delphi study on barriers to the implementation of a national clinical pharmacy practice guideline – results from Bulgaria Home Articles About About Pensoft Books Journals Blog Register | Login Research Article Pharmacia 73: e189960 https://doi.org/10.3897/pharmacia.73.e189960 (22 Apr 2026) Other versions: (Verbatim name) ID (Catalog Number) DES Invalid DOI was provided, please try again XML PDF Bluesky Twitter Facebook Telegram Mendeley Reddit Notify a colleague Contents Contents Article Info Article Info Cite Cite Metrics Metrics Comment Comment Related Related Figs Figs Tabs Tabs Refs Refs Cited Cited Ranking of barriers according to expert-assigned importance. This figure presents the ranking of identified barriers according to expert assessment. Each row represents an individual expert and each column a barrier category. Marked cells indicate the barrier selected as the top priority by a given expert, illustrating the distribution of expert opinions. The barrier names are shortened in the figure for readability. Full descriptions are as follows: Training – “Insufficient practical training of clinical pharmacists during specialty education”; Regulation – “Lack of a comprehensive regulatory framework for clinical pharmacy practice or insufficient enforcement of existing regulations”; Workforce – “Insufficient number of clinical pharmacists working in hospital settings”; Acceptance – “Limited acceptance of clinical pharmacists by medical teams and hospital administration”; Remuneration – “Low remuneration of pharmacists working in hospital settings”; Administration – “Lack of administrative will and implementation capacity.” Six of the 12 barriers (50%) were designated as most important by at least one expert. The highest mean ranks were observed for “Insufficient practical training of clinical pharmacists during specialty education” and “Lack of a comprehensive regulatory framework for clinical pharmacy practice or insufficient enforcement of existing regulations”. Kendall’s coefficient indicated a moderate and statistically significant degree of concordance (W = 0.320; p = 0.003). Subscribe to email alerts for current Article's categories Powered by This website uses cookies in order to improve your web experience. Read our Cookies Policy OK

Related documents

• Development & Pilot of the Technology-Enabled Alliance for Medication Therapy Management#1031491
• Expanding the Role of Pharmacists in Treating Persons With Cardiovascular or Lung Diseases#895507
• Supporting Prescribing in Irish Primary Care: General Practice Pharmacist Study#832066
• How Can We Make Information on Equity in Clinical Guidelines More Usable for Clinicians? A Case Study Methodology of General Practitioners#313027
• ALIGN: Aligning Medications With What Matters Most (Demonstration)#900501